Integrated approach for optimization of the treatment of multimorbid elderly patients with dementia

The CAREPATH project, which was inaugurated on July 1, 2021, is a European Horizon 2020 project that proposes an ICT-based solution that will improve clinical practice in the treatment and management of patients who have multiple comorbidities, such as mild cognitive impairment (MCI) and mild dementia (MD). The CAREPATH project solution targets a more complex multimorbidity situation and uses a holistic patient-centered model to create an adaptable and modular system that provides optimal care and adaptable frameworks that enable multimorbid patients with dementia to enhance their independence and quality of life (QoL).

CAREPATH project is focused on the improvement of healthcare interventions to treat of conditions of elderly multimorbid patients, which present many problems for Europe as the existing healthcare systems are still primarily focused on single diseases. Multimorbidity is a growing trend with age and is a major driver of healthcare costs and sustainability worldwide. Multimorbidity in dementia creates a more complex situation. There isn’t a clear and optimum treatment plan for patients with multiple maladies with dementia.

People who have two or more chronic illnesses, who are also suffering from dementia, tend to be more at risk than those without dementia The reason is that a) multimorbidity can impact their dementia, leading to an acceleration in the progression of dementia, and b) dementia can make it more difficult to manage their multiple conditions, by hindering their management.

Statistics worldwide are supporting these observations:

  • 91.8 percent of those living with dementia are multimorbid:
  • 13.2 percent with an additional condition
  • 33.8 percent, with two to three additional conditions
  • 27.8 percent with four to five additional conditions
  • 16.9 percent for six or more conditions

People with dementia are typically affected by diabetes and heart disease. Patients and their families are difficult to live with multiple illnesses. For instance cognitive impairment impacts a patient’s capacity for self-management of multimorbidity, thus contributing to the rising number of hospitalizations. In the UK alone between 45 to 58% of patients with dementia and one of stroke, diabetes or vision impairment, used hospital services at least once in the year, as opposed to a third without any of these conditions.

CAREPATH project proposes an Integrated Care Platform that jointly addresses dementia, multimorbidity, and reduced substantial capacity and effectively manages healthcare interventions for its users (patients, informal caregiver health professionals, patients, etc.

The project will conduct a Technical Validation and Usability (TVU) study involving over 45 users as well as Clinical Investigation (CI) involving more than 200 patients. The study will be conducted in four European countries (Spain, Romania, Germany and the UK). On the other hand, presenting guideline for Dementia/Multimorbidity that will be conceived for best healthcare delivery. Additionally, the CAREPATH project will also introduce an Health Economics Impact Assessment for healthcare cost effectiveness and care equalization.

Finally, the CAREPATH consortium is well-balanced in terms of geographical spread. Ten partners are from six countries. The consortium is comprised of three categories of partners that include two universities four clinical partners, one R&D Center and four SMEs. The project is managed by the company ECLEXYS SAGL Switzerland.

Fraunhofer FIT is a consortium member and is responsible for gathering user requirements conducting usability tests, and designing a corresponding architecture. Fraunhofer FIT will also develop and integrate the polypharmacy module for the CAREPATH platform.

Content Source:

Gemma Wilson

Gemma is a journalism graduate with keen interest in covering business news – specifically startups. She has as a keen eye for technologies and has predicted quite a few successful startups over the last couple of years.

Related Articles